Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 pandemic has affected countries worldwide, and Mauritius is no exception. The country has witnessed a surge in demand for COVID-19 vaccines as it battles the pandemic.
Customer preferences: Mauritians have shown a willingness to get vaccinated against COVID-19. The government has launched a vaccination campaign to vaccinate the population, and the response has been positive. The majority of the population is eager to get vaccinated as they understand the importance of vaccination in controlling the spread of the virus.
Trends in the market: The COVID-19 vaccine market in Mauritius is developing at a rapid pace. The government has secured vaccines from various manufacturers, and the vaccination campaign is in full swing. The demand for vaccines is high, and the government is working to ensure that everyone who wants to get vaccinated can do so. The private sector has also joined in the effort, with some companies offering vaccination to their employees.
Local special circumstances: Mauritius is a small island nation with a population of around 1.3 million people. The country relies heavily on tourism, which has been severely impacted by the pandemic. The government has implemented strict measures to control the spread of the virus, including closing borders and imposing lockdowns. The vaccination campaign is seen as a way to revive the tourism industry and boost the economy.
Underlying macroeconomic factors: Mauritius has a relatively stable economy, but the pandemic has had a significant impact. The country has experienced a decline in GDP, and the unemployment rate has risen. The government has implemented various measures to support businesses and individuals affected by the pandemic. The vaccination campaign is seen as a way to control the spread of the virus and allow the economy to reopen. In conclusion, the COVID-19 vaccine market in Mauritius is developing rapidly as the government and private sector work to vaccinate the population. The high demand for vaccines is driven by customer preferences and the need to revive the economy. The government's efforts to secure vaccines and launch a vaccination campaign are crucial in controlling the spread of the virus and allowing the country to recover from the pandemic's impact.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
